Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: a novel agonist 5-HT1A receptor PET ligand

Bioorg Med Chem Lett. 2006 Apr 15;16(8):2101-4. doi: 10.1016/j.bmcl.2006.01.052. Epub 2006 Feb 3.

Abstract

Synthesis and in vivo evaluation of 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione (5 or MMT), a high affinity and selective serotonin 5-HT1AR agonist PET tracer, are described. GTPgammaS assay shows that MMT is an agonist with an EC50 comparable to 5-HT. Radiolabeling of 5 was achieved in 30% yield (EOS) from desmethyl-MMT (4) with >99% chemical and radiochemical purities and a specific activity >1000 Ci/mmol. PET studies in baboon show that [11C]5 penetrates the blood-brain barrier but, because of low specific binding and fast clearance of radioactivity it is not a suitable PET tracer for the in vivo quantification of 5-HT1AR.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Animals
  • Brain / diagnostic imaging
  • CHO Cells
  • Cricetinae
  • Diterpenes / isolation & purification*
  • Diterpenes / pharmacology
  • Ligands
  • Magnetic Resonance Imaging
  • Papio
  • Positron-Emission Tomography
  • Radioligand Assay / methods*
  • Serotonin 5-HT1 Receptor Agonists*
  • Triazines / chemical synthesis
  • Triazines / pharmacology

Substances

  • Diterpenes
  • Ligands
  • Serotonin 5-HT1 Receptor Agonists
  • Triazines
  • celahypodiol 1